RE

Replay Therapeutics

4 known investors

replay.bio ↗

Creating a toolkit to deliver large DNA payloads to any cell type for the cell and gene therapy market.

Investors · 4

AR

Artis VenturesSan Francisco · $50K – $25M

OM

OMX VenturesLincolnshire

SO

Solari CapitalNew York

AX

Axial VCreportedSan Francisco · $100K – $5M